Agile Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2019-03-14: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-03-04; Total offering amount $7,836,878.
- 2015-02-06: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-01-23; Total offering amount $20,000,000.
- 2012-07-31: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2012-07-18; Total offering amount $40,675,995.
- 2011-07-11: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2010-05-25; Total offering amount $45,100,660.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2019-03-14 | Rule 506(b) | Equity | 2019-03-04 | $7,836,878 | $7,836,878 | $0 | 1 |
| 2015-02-06 | Rule 506(b) | Equity | 2015-01-23 | $20,000,000 | $20,000,000 | $0 | 8 |
| 2012-07-31 | Rule 506 | Equity | 2012-07-18 | $40,675,995 | $23,676,000 | $16,999,995 | 13 |
| 2011-07-11 D/A | Rule 506 | Equity | 2010-05-25 | $45,100,660 | $33,060,670 | $12,039,990 | 14 |
| 2010-06-07 | Rule 506 | Equity | 2010-05-25 | $45,010,660 | $23,344,028 | $21,666,632 | 11 |